Novo Integrated Sciences, Inc. announced Novo Healthnet Limited completed the acquisition of Acenzia Inc. Indrajit “Indra” Sinha Ph.D. who assumes the roles and responsibilities as the Company’s Chief Science Officer (CSO) to include focusing on the continued development of Acenzia’s proprietary oncology research technology, as well as several other Novo proprietary product and science assets.